Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Telemedicine minimum viable product for post-exposure prophylaxis to biological material in the COVID-19 pandemic
2
Zitationen
5
Autoren
2023
Jahr
Abstract
The integration of tools already available on the internet allows a professional outside the field of information technology to develop a minimum viable telemedicine product, aiming to maintain health care and avoid the crowding of patients in outpatient clinics. We suggest the development of a robust tool that integrates several routines for monitoring cases of exposure to biological material.
Ähnliche Arbeiten
Virtually Perfect? Telemedicine for Covid-19
2020 · 3.033 Zit.
Beyond Adoption: A New Framework for Theorizing and Evaluating Nonadoption, Abandonment, and Challenges to the Scale-Up, Spread, and Sustainability of Health and Care Technologies
2017 · 2.432 Zit.
CONSORT-EHEALTH: Improving and Standardizing Evaluation Reports of Web-based and Mobile Health Interventions
2011 · 1.975 Zit.
The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence
2020 · 1.896 Zit.
Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19)
2020 · 1.844 Zit.